Houston-based Nobilis Health received a delisting notice from the New York Stock Exchange, and its CFO and chief legal officer have resigned, according to the Houston Business Journal.
The NYSE American suspended trading of Nobilis' stock after markets closed Sept. 3 because the company has not filed an earnings report since the second quarter of 2018. Nobilis needed to file its earnings reports by Aug. 31 to continue listing its stock on the NYSE, according to the report.
Nobilis will not appeal the delisting, which is expected to become effective in late September, according to the Houston Business Journal, which cited filings with the Securities and Exchange Commission.
Nobilis also announced that two executives resigned. Brandon Moreno, the company's CFO, and Marissa Arreola, chief legal officer, resigned Sept. 6. Details about their departures were not included in the SEC filing.
Nobilis owns, operates, manages or co-manages more than 60 hospitals, clinics and ambulatory care centers in Texas and Arizona, according to the company's website. Nobilis recorded nearly $300 million in revenue in 2017, which is the most recent annual report available, according to the Houston Business Journal.
Access the full Houston Business Journal article here.
More articles on healthcare finance:
7 health systems with strong finances
Sutter Health faces class-action lawsuit over pricing: 4 things to know
Nonprofit hospital revenue growth exceeds expense growth for first time in 3 years, Moody's finds